Fortvita Biologics (usa)inc.
Clinical trials sponsored by Fortvita Biologics (usa)inc., explained in plain language.
-
New hope for tough lung cancer: experimental drug IBI363 faces chemo in major trial
Disease control Recruiting nowThis phase 3 study tests whether a new drug called IBI363 works better than the standard chemotherapy docetaxel for people with advanced squamous non-small cell lung cancer that has worsened after platinum chemo and immunotherapy. About 600 adults will be randomly assigned to rec…
Phase: PHASE3 • Sponsor: Fortvita Biologics (USA)Inc. • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New drug IBI3032 put to the test in healthy volunteers – no treatment intended
Knowledge-focused Recruiting nowThis early-stage study tests the safety and how the body processes a single dose of IBI3032 in 32 healthy adults. Participants are randomly assigned to receive either the drug or a placebo. The goal is only to gather safety information, not to treat any disease.
Phase: PHASE1 • Sponsor: Fortvita Biologics (USA)Inc. • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC